François Pierre Combes

6PUBLICATIONS
7CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCheminformatics and quantitative structure-activity relationshipsSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 29, 2024
Clinical Pharmacology of Asciminib: A Review.

Matthias Hoch, Felix Huth, Paul William Manley

|Sep 07, 2024
Dose Justification for Asciminib in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia with and Without the T315I Mutation.

Francois Pierre Combes, Sherwin K B Sy, Ying Fei Li

|Aug 17, 2022
Correction to: Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases.

Ying Fei Li, Francois Pierre Combes, Matthias Hoch

|Jul 01, 2022
Exposure-Efficacy Analysis of Asciminib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase.

François Pierre Combes, Ying Fei Li, Matthias Hoch

|Jun 28, 2022
Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases.

Ying Fei Li, Francois Pierre Combes, Matthias Hoch

|Jul 12, 2018
Population pharmacokinetics-pharmacodynamics of oral everolimus in patients with seizures associated with tuberous sclerosis complex.

François Pierre Combes, Guillaume Baneyx, Neva Coello

Pageof 1

Frequent Collaborators

4 joint publications

Sherwin K B Sy

3 joint publications

Ying Fei Li

1 joint publications

Matthias Hoch

1 joint publications

Felix Huth